Early detection and management of Alzheimer's Disease through multi‐omic analysis of blood

Abstract

Background: Alzheimer's disease (AD), a leading cause of dementia, poses a global health challenge as aging populations expand. Traditionally, practitioners rely on symptom‐based identification, often miss the critical window for early intervention, limiting opportunities for improved clinical outcomes.

The paper